Evidence map›Paper›PMID 34053885›Full record

ArticleHeart, lung & circulation2021

Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID).

Patricia O'Sullivan, John Younger, Niels Van Pelt, Sue O'Malley, Dora Lenturut-Katal, Cole B Hirschfeld, Joao V Vitola, Rodrigo Cerci, Michelle C Williams, Leslee J Shaw and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heart, lung & circulation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Nuclear Cardiology in the COVID-19 pandemic.Revista espanola de medicina nuclear e imagen molecular
    Article
  6. [Nuclear Cardiology in the COVID-19 pandemic].Revista espanola de medicina nuclear e imagen molecular
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Patricia O'SullivanRoyal Melbourne Hospital, Melbourne, Vic, Australia.
John YoungerRoyal Brisbane Hospital, Brisbane, Qld, Australia; University of Queensland, Brisbane, Qld, Australia.
Niels Van PeltMiddlemore Hospital, Auckland, New Zealand.
Sue O'MalleyChristchurch Hospital, Christchurch, New Zealand.
Dora Lenturut-KatalPort Moresby General Hospital, Papua New Guinea.
Cole B HirschfeldDepartment of Medicine, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, NY, USA.
Joao V VitolaQuanta Diagnostico, Curitiba, Brazil.
Rodrigo CerciQuanta Diagnostico, Curitiba, Brazil.
Michelle C WilliamsBHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Leslee J ShawDepartment of Medicine, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.
Paolo RaggiDepartment of Medicine and Division of Cardiology, University of Alberta, Edmonton, Canada.
Todd C VillinesUniversity of Virginia, Charlottesville, VA, USA.
Sharmila DorbalaBrigham and Women's Hospital, Boston, WA, USA.
Andrew D ChoiThe George Washington University School of Medicine, Washington, DC, USA.
Yosef CohenTechnion Israel Institute of Technology, Haifa, Israel.
Benjamin GoebelDepartment of Medicine, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.
Eli MalkovskiyDepartment of Medicine, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, NY, USA; Seymour, Paul and Gloria Milstein Division of Cardiology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, NY, USA.
Michael RandazzoDepartment of Medicine, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, NY, USA.
Thomas N B PascualPhilippines Nuclear Research Institute, Manila, Philippines.
Yaroslav PyndaInternational Atomic Energy Agency, Vienna, Austria.
Maurizio DondiInternational Atomic Energy Agency, Vienna, Austria.
Diana PaezInternational Atomic Energy Agency, Vienna, Austria.
Andrew J EinsteinDepartment of Medicine, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, NY, USA; Seymour, Paul and Gloria Milstein Division of Cardiology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, NY, USA; Department of Radiology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, NY, USA.
Nathan BetterRoyal Melbourne Hospital, Melbourne, Vic, Australia; University of Melbourne, Melbourne, Vic, Australia. Electronic address: nathan.better@mh.org.au.
INCAPS COVID Investigators Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe INCAPS COVID Oceania study aimed to assess the impact caused by the COVID-19 pandemic on cardiac procedure volume provided in the Oceania region.

methodsA retrospective survey was performed comparing procedure volumes within March 2019 (pre-COVID-19) with April 2020 (during first wave of COVID-19 pandemic). Sixty-three (63) health care facilities within Oceania that perform cardiac diagnostic procedures were surveyed, including a mixture of metropolitan and regional, hospital and outpatient, public and private sites, and 846 facilities outside of Oceania. The percentage change in procedure volume was measured between March 2019 and April 2020, compared by test type and by facility.

resultsIn Oceania, the total cardiac diagnostic procedure volume was reduced by 52.2% from March 2019 to April 2020, compared to a reduction of 75.9% seen in the rest of the world (p<0.001). Within Oceania sites, this reduction varied significantly between procedure types, but not between types of health care facility. All procedure types (other than stress cardiac magnetic resonance [CMR] and positron emission tomography [PET]) saw significant reductions in volume over this time period (p<0.001). In Oceania, transthoracic echocardiography (TTE) decreased by 51.6%, transoesophageal echocardiography (TOE) by 74.0%, and stress tests by 65% overall, which was more pronounced for stress electrocardiograph (ECG) (81.8%) and stress echocardiography (76.7%) compared to stress single-photon emission computerised tomography (SPECT) (44.3%). Invasive coronary angiography decreased by 36.7% in Oceania.

conclusionA significant reduction in cardiac diagnostic procedure volume was seen across all facility types in Oceania and was likely a function of recommendations from cardiac societies and directives from government to minimise spread of COVID-19 amongst patients and staff. Longer term evaluation is important to assess for negative patient outcomes which may relate to deferral of usual models of care within cardiology.

Indexed as

CardiologyCOVID-19HumansPandemicsRetrospective StudiesSARS-CoV-2Tomography, X-Ray ComputedCardiac imagingCardiac investigationsCoronavirusCOVID-19

Identifiers

PMID34053885
PMCPMC8126176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.